Research never stops

Top Story

Evotec receives pre-clinical milestone as part of its Endometriosis Alliance with Bayer

Hamburg, Germany, 22 May 2017:
Evotec AG announced today that its multi-target endometriosis alliance with Bayer has reached another significant pre-clinical milestone, triggering a payment of approx. EUR 5 m to Evotec for the transition of a programme into pre-clinical development for the treatment of endometriosis.

- read more

Evotec announces first quarter results 2017 and corporate update

Hamburg, Germany, 10 May 2017: Evotec AG today reported financial results and corporate updates for the first quarter of 2017.

- read more

Evotec achieves first milestone in Diabetes alliance with Sanofi

Hamburg, Germany 05 April 2017: Evotec AG today announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached an important milestone, triggering a payment of EUR 3.0 m to Evotec, for achieving pre-clinical proof-of-concept.

- read more
loading weather report
Loading weather report...


Jun 21, 2017 - dbAccess Berlin Conference

Company Presentation May

Building integrated and high-value drug discovery alliances
2017-05_Evotec_Company presentation_May